Regulatory Challenges in the CIS and Russia - TOPRA In CEE Webinar
November 22, 2023
July 20, 2021
New Inpharmatis Head office phone number
We would like to inform you that the Inpharmatis Head office in Riga, Latvia phone number has been changed to +371 6000 3500. These changes were made in order to have several direct phone lines for different business processes. Other official company details of Inpharmatis remain the same.
Please, feel free to contact us on Inpharmatis products and services, such as regulatory affairs in EU, EAEU, and CIS, eSolutions for the pharmaceutical industry, PIL User testing, etc.
You can still contact us via email info@inpharmatis.com.
Особенности выбора типа Пользовательского тестирования листка-вкладыша в ЕАЭС
November 01, 2023
Features of Choosing the Type of PIL RUT in EAEU
November 01, 2023
PIL Readability User Testing in EAEU Special Autumn Offer
October 25, 2023
Специальное Осеннее Предложение по пользовательскому тестированию листка-вкладыша
October 24, 2023
PIL Readability Testing is Mandatory in EAEU
February 15, 2022
Пользовательское тестирование по ЕАЭС – обязательная процедура
February 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical Sciences
January 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук больше
January 27, 2022
Pharma 4.0: Data-Driven Regulation
January 18, 2022